{"id":658085,"date":"2026-03-15T20:02:14","date_gmt":"2026-03-15T20:02:14","guid":{"rendered":"https:\/\/www.europesays.com\/us\/658085\/"},"modified":"2026-03-15T20:02:14","modified_gmt":"2026-03-15T20:02:14","slug":"should-you-take-glp-1-drugs-for-longevity","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/658085\/","title":{"rendered":"Should you take GLP-1 drugs for longevity?"},"content":{"rendered":"<p>This is, indeed, part of a wider trend of mutual support at the fringes of pharmacology, with similar user groups forming to monitor off-label use of peptide drugs and thus, in effect, running informal, uncontrolled trials. Whether those now taking GLP-1 RAs prophylactically will live to regret doing that or, conversely, will live long enough not to, remains to be seen.<\/p>\n","protected":false},"excerpt":{"rendered":"This is, indeed, part of a wider trend of mutual support at the fringes of pharmacology, with similar&hellip;\n","protected":false},"author":3,"featured_media":658086,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[55948,210,69018,278764,1060,15209,24040,67,132,68],"class_list":{"0":"post-658085","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-glp-1-receptor-agonists","9":"tag-health","10":"tag-healthspan","11":"tag-healthy-people","12":"tag-medication","13":"tag-semaglutide","14":"tag-type-2-diabetes","15":"tag-united-states","16":"tag-unitedstates","17":"tag-us"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/116234980239710996","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/658085","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=658085"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/658085\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/658086"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=658085"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=658085"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=658085"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}